NEUARTIGE CRISPR-ENZYME UND -SYSTEME

European patent · EP3009511 · In force

Register entry

Publication number
EP3009511
Application number
EP16150428
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Maintained in amended form
Filed
Jan 7, 2016
Published
Apr 20, 2016
Granted
May 31, 2017
Protection ends at the latest
Jan 6, 2036
Next annual fee due
Jan 31, 2027
IPC classes
C12N 15/113 (2010.01)
C12N 15/10 (2006.01)
C12N 9/22 (2006.01)
C12N 15/82 (2006.01)
Priority
US 201562181739 P 18.06.2015
US 201562193507 P 16.07.2015
US 201562201542 P 05.08.2015
US 201562205733 P 16.08.2015
US 201562232067 P 24.09.2015
US 201514975085 18.12.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Dec 30, 2020

    Change

    Published in Swissreg on 30.12.2020

  6. May 31, 2017

    Granted

    Published in Swissreg on 31.05.2017

Parties

Holder

The Broad Institute, Inc.

415 Main Street, Cambridge, MA 02142, US

Massachusetts Institute of Technology

MASSACHUSETTS INSTITUTE OF TECHNOLOGY

77 Massachusetts Avenue, Cambridge, MA 02142-1324, US

President and Fellows of Harvard College

17 Quincy Street, Cambridge, MA 02138, US

Inventor

Zhang, Feng

Cambridge, MA 02139, US

Zetsche, Bernd

Gloucester, MA 09130, US

Gootenberg, Jonathan

Cambridge, MA 02138, US

Abudayyeh, Omar

Boston, MA 02114, US

Slaymaker, Ian

Cambridge, MA 02142, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.